RAY QUENNEVILLE: Open Payments
NPI 1730153875 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 29 payments from 11 companies in 2025. Trend: 2023 $603 · 2024 $612 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $168 |
| GlaxoSmithKline, LLC. | 10 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Antares Pharma, Inc. | 2 | $50 |
| PFIZER INC. | 1 | $28 |
| Seqirus USA Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: VRAYLAR, AREXVY, CAPLYTA, XYOSTED, NURTEC ODT, SHINGRIX, BEXSERO, Fluad.
Industry payments across CO — which companies pay providers there.
